Sale!

Pre-implantation Genetic Disorder PGD HLA Typing Single Embryo Test

Original price was: 8,000 د.إ.Current price is: 4,400 د.إ.

-45%

Pre-implantation Genetic Diagnosis (PGD) with HLA Typing is a sophisticated reproductive technology used in conjunction with in vitro fertilization (IVF) to help identify genetic defects within embryos. This process also includes typing of the human leukocyte antigen (HLA) to ensure that the selected embryo can be a potential donor for an existing sibling requiring a stem cell transplant. The single embryo test is meticulously designed to screen for a wide range of genetic disorders and ensure the embryo’s compatibility with the HLA type of a family member, significantly increasing the chances of a successful transplant and treatment of genetic diseases.

At DNA Labs UAE, this highly specialized test is offered at a cost of 4400 AED. The lab utilizes cutting-edge technology and adheres to stringent quality standards to provide accurate and reliable results. By opting for the PGD with HLA Typing Single Embryo Test, prospective parents are given a chance to not only bring a healthy child into the world but also potentially save the life of an existing child with a genetic disorder, making it a valuable option for families facing complex genetic health challenges.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Pre-implantation Genetic Disorder/PGD HLA Typing Single Embryo Test

Test Name: Pre-implantation Genetic Disorder/PGD HLA Typing Single Embryo Test

Components: Please request collection material

Price: 4400.0 AED

Sample Condition: Trophectoderm

Report Delivery: 3 weeks

Method: Sanger Sequencing

Test Type: Genetics

Doctor: Gynecologist

Test Department: Pre Test Information

Pre Test Information

Pre-implantation Genetic Disorder/PGD HLA Typing (Single Embryo) can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

Pre-implantation Genetic Disorder/PGD HLA Typing (Single Embryo) is a type of genetic testing that is performed during the in vitro fertilization (IVF) process. This test is used to determine if a single embryo is a match for a sibling who requires a bone marrow transplant.

The test involves removing one or two cells from the embryo and analyzing them to determine the human leukocyte antigen (HLA) type. HLA is a group of proteins found on the surface of cells that play a critical role in the immune system’s ability to recognize and respond to foreign substances.

If the embryo is a match for the sibling in need of a bone marrow transplant, it can be implanted into the mother’s uterus, and the baby can be born and used as a donor for the sibling.

This type of testing is typically recommended for families who have a child with a life-threatening genetic disorder that can be treated with a bone marrow transplant.

PGD HLA Typing is a controversial topic as it involves selecting embryos based on their genetic makeup. Critics argue that it raises ethical concerns and could lead to the creation of “designer babies.” However, proponents argue that it provides a life-saving option for families in need and can prevent the birth of a child with a genetic disorder.

Test Name Pre-implantation Genetic DisorderPGD HLA Typing Single Embryo Test
Components Please request collection material
Price 4400.0 AED
Sample Condition Trophectoderm
Report Delivery 3 weeks
Method Sanger Sequencing
Test type Genetics
Doctor Gynecologist
Test Department:
Pre Test Information Pre-implantation Genetic Disorder/PGD HLA Typing (Single Embryo) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

Pre-implantation Genetic Disorder/PGD HLA Typing (Single Embryo) is a type of genetic testing that is performed during the in vitro fertilization (IVF) process. This test is used to determine if a single embryo is a match for a sibling who requires a bone marrow transplant.

The test involves removing one or two cells from the embryo and analyzing them to determine the human leukocyte antigen (HLA) type. HLA is a group of proteins found on the surface of cells that play a critical role in the immune system’s ability to recognize and respond to foreign substances.

If the embryo is a match for the sibling in need of a bone marrow transplant, it can be implanted into the mother’s uterus, and the baby can be born and used as a donor for the sibling. This type of testing is typically recommended for families who have a child with a life-threatening genetic disorder that can be treated with a bone marrow transplant.

PGD HLA Typing is a controversial topic as it involves selecting embryos based on their genetic makeup. Critics argue that it raises ethical concerns and could lead to the creation of “designer babies.” However, proponents argue that it provides a life-saving option for families in need and can prevent the birth of a child with a genetic disorder.